PFBT
IRMD icon

Parkside Financial Bank & Trust’s iRadimed IRMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3K Hold
190
– – ﹤0.01% 1338
2025
Q4 		$18.5K Hold
190
– – ﹤0.01% 1329
2025
Q3 		$13.5K Hold
190
– – ﹤0.01% 1398
2025
Q2 		$11.4K Buy
+190
New +$10.4K ﹤0.01% 1445

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's IRMD Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its iRadimed (IRMD) position steady in Q1 2026 at 190 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Parkside Financial Bank & Trust first reported a position in IRMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $18.5K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Parkside Financial Bank & Trust held 190 shares of iRadimed worth $18.3K as of Q1 2026.
  • Parkside Financial Bank & Trust left its iRadimed share count unchanged in Q1 2026.
  • iRadimed made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1338 holding.
  • Parkside Financial Bank & Trust first reported a position in iRadimed in Q2 2025 and has held it in 4 quarters since.
  • Parkside Financial Bank & Trust's iRadimed position peaked at $18.5K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.